NEW YORK, March 22, 2022 /PRNewswire/ -- Brilliant
Acquisition Corporation ("Brilliant") announced today that it has
extended the period of time it will have to consummate its initial
business combination by a further four months, or until
July 23, 2022. In connection
with the extension, Brilliant's Sponsor, Nisun Investment Holding
Limited has timely deposited $634,594
in Brilliant's trust account, representing $0.16 per public ordinary share of Brilliant that
was not redeemed in connection with the shareholder vote to approve
the extension, as additional interest on the proceeds in the trust
account.
The purpose of the extension is to permit sufficient time for
Brilliant to consummate its previously announced proposed business
combination with Nukkleus Inc. ("Nukkleus"), including filing a
registration statement on Form S-4 that will include a proxy
statement. The extension was approved by Brilliant's shareholders
on March 18, 2022. For a
summary of the material terms of the proposed business combination,
please see Brilliant's Current Report on Form 8-K filed on
February 23, 2022, with the U.S.
Securities and Exchange Commission (the "SEC") in connection with
the announcement of the proposed business combination.
About Brilliant Acquisition Corp.
Brilliant (Nasdaq: BRLI) is a blank check company organized for
the purpose of effecting a merger, share exchange, asset
acquisition, or other similar business combination with one or more
businesses or entities.
Additional Information and Where to Find It
This press release relates to a proposed business combination
transaction between Nukkleus and Brilliant pursuant to which
Nukkleus will become the parent company of Brilliant upon the
closing of the transactions. In connection with the proposed
transaction, Nukkleus intends to file with the SEC a registration
statement on Form S-4, including a proxy statement (the "proxy
statement"). The definitive proxy statement (if and when available)
will be delivered to Nukkleus's and Brilliant's shareholders. Each
of Nukkleus and Brilliant may also file other relevant documents
regarding the proposed transaction with the SEC. BEFORE MAKING ANY
VOTING OR INVESTMENT DECISION, INVESTORS AND SECURITY HOLDERS OF
NUKKLEUS AND BRILLIANT ARE URGED TO READ THE REGISTRATION
STATEMENT, PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS THAT
ARE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION,
INCLUDING ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS,
CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT
INFORMATION ABOUT THE PROPOSED TRANSACTION.
Investors and security holders may obtain free copies of the
proxy statement (if and when available) and other documents that
are filed or will be filed with the SEC by Nukkleus or Brilliant
through the website maintained by the SEC at www.sec.gov.
Stockholders of Nukkleus will also be able to obtain a copy of the
definitive proxy statement, without charge by directing a request
to: Nukkleus, Inc., 525 Washington Boulevard, Jersey City, New Jersey 07310. Shareholders of
Brilliant will also be able to obtain a copy of the definitive
proxy statement, without charge by directing a request to:
Brilliant Acquisition Corporation, 99 Dan Ba Road, C-9, Putuo
District, Shanghai, Peoples Republic of China.
Participants in the Solicitation
Nukkleus and its directors and executive officers are
participants in the solicitation of proxies from the stockholders
of Nukkleus in respect of the proposed transaction. Information
about Nukkleus's directors and executive officers and their
ownership of Nukkleus common stock is set forth in Nukkleus's
Annual Report on Form 10-K for the year ended September 30, 2021, filed with the SEC on
December 29, 2021. Other information
regarding the participants in the proxy solicitation and a
description of their direct and indirect interests, by security
holdings or otherwise, will be contained in the proxy
statement/prospectus and other relevant materials to be filed with
the SEC in respect of the proposed transaction when they become
available. You may obtain free copies of these documents as
described in the preceding paragraph.
Brilliant and its directors and executive officers are
participants in the solicitation of proxies from the shareholders
of Brilliant in respect of the proposed transaction. Information
about Brilliant's directors and executive officers and their
ownership of Brilliant's ordinary shares is set forth in
Brilliant's Annual Report on Form 10-K for the year ended
December 31, 2020, filed with the SEC
on October 13, 2021. Other
information regarding the participants in the proxy solicitation
and a description of their direct and indirect interests, by
security holdings or otherwise, will be contained in the proxy
statement/prospectus and other relevant materials to be filed with
the SEC in respect of the proposed transaction when they become
available. You may obtain free copies of these documents as
described above.
Forward Looking Statements
This press release includes forward-looking statements that
involve risks and uncertainties. Forward looking statements are
statements that are not historical facts. Such forward-looking
statements are subject to risks and uncertainties, which could
cause actual results to differ from the forward-looking statements.
Brilliant expressly disclaims any obligations or undertaking to
release publicly any updates or revisions to any forward-looking
statements contained herein to reflect any change in Brilliant's
expectations with respect thereto or any change in events,
conditions or circumstances on which any statement is based.
Contact:
Dr. Peng Jiang
Chief Executive Officer
Brilliant Acquisition Corporation
+ (86) 021-80125497
View original
content:https://www.prnewswire.com/news-releases/brilliant-acquisition-corporation-announces-extension-of-completion-window-to-july-23-2022-301507553.html
SOURCE BRILLIANT ACQUISITION CORPORATION